Be The Match BioTherapies® Marks Cord Blood Awareness Month with the Announcement of the Cord Blood Bank Alliance
July 10, 2023 09:40 ET
|
Be The Match
MINNEAPOLIS, July 10, 2023 (GLOBE NEWSWIRE) -- In anticipation of Cord Blood Awareness Month this July, Be The Match BioTherapies®, an organization offering solutions for companies developing and...
The International Myeloma Foundation’s Nurse Leadership Board Launches Myeloma University
July 06, 2023 08:45 ET
|
International Myeloma Foundation
LOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation’s (IMF) Nurse Leadership Board (NLB) today announced the launch of Myeloma University—a FREE online educational...
Global Hematology Analyzer Markets Report 2023: 2020-2023 Data & CAGR Projections Through 2028
June 21, 2023 07:48 ET
|
Research and Markets
Dublin, June 21, 2023 (GLOBE NEWSWIRE) -- The "Hematology Analyzer Market" report has been added to ResearchAndMarkets.com's offering.The global market for hematology analyzers was valued at $3.8...
Patient & Provider Advocates Applaud Senate Reintroduction of the Cancer Drug Parity Act
June 15, 2023 19:00 ET
|
International Myeloma Foundation
WASHINGTON, June 15, 2023 (GLOBE NEWSWIRE) -- The Coalition to Improve Access to Cancer Care (CIACC) and its members from across the cancer patient and provider community today applauded Senators...
ADC Therapeutics Announces Evolution of Board of Directors
June 15, 2023 07:15 ET
|
ADC Therapeutics SA
Strengthens the Board with the election of Robert W. Azelby as director Board will be comprised of nine directors; gratitude expressed for contributions of outgoing directors LAUSANNE,...
Precipio’s Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy
June 14, 2023 09:49 ET
|
Precipio, Inc.
NEW HAVEN, Conn., June 14, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. leveraged its proprietary HemeScreen Cytopenia panel as part of the diagnostic process for...
Global Multiple Myeloma Market Research Report 2023-2030: Top 10 Markets, Epidemiology, Marketed Products, Pipeline Drugs, Patient Journey, Competitive Landscape
June 12, 2023 07:08 ET
|
Research and Markets
Dublin, June 12, 2023 (GLOBE NEWSWIRE) -- The "Multiple Myeloma Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis"...
Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio’s Platform
June 09, 2023 07:30 ET
|
Vor Biopharma
Patients transplanted with trem-cel achieved primary neutrophil engraftment and high levels of myeloid donor chimerism.Strong investigator enthusiasm and continued robust enrollment; additional data...
ADC Therapeutics Announces Updated LOTIS-2 Results Demonstrating Durable, Long-Term Responses of ZYNLONTA® in Relapsed/Refractory DLBCL
June 09, 2023 07:15 ET
|
ADC Therapeutics SA
LAUSANNE, Switzerland, June 09, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced updated results from LOTIS-2, the pivotal Phase 2 clinical trial of ZYNLONTA® (loncastuximab...
Vor Bio to Participate in the Goldman Sachs Healthcare Conference
June 05, 2023 08:00 ET
|
Vor Biopharma
CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will present and host in-person 1x1 investor meetings at the Goldman...